pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
JBI-778
Adenoid Cystic Carcinoma (ACC)
Jubilant Therapeutics Inc
0 catalysts
Phase 2
JBI-802
Neuroendocrine Tumors
Jubilant Therapeutics Inc
0 catalysts
Preclinical
JBTmiR-2
Coronary Artery Disease (CAD) (Ischemic Heart Disease)
Jaan Biotherapeutics Inc
0 catalysts
Phase 1
JBZ-001
Diffuse Large B-Cell Lymphoma
← prev
page 112 of 271
next →
131
Pain89
Neurology1
Jabez Biosciences Inc
0 catalysts
Phase 2
JCXH-105
Herpes Zoster (Shingles)
Immorna Hangzhou Biotechnology Co Ltd
0 catalysts
Phase 2
JCXH-107
Seasonal Influenza
Immorna Hangzhou Biotechnology Co Ltd
0 catalysts
Phase 2
JCXH-221
Coronavirus Disease 2019 (COVID-19)
Immorna Hangzhou Biotechnology Co Ltd
0 catalysts
Preclinical
JD-004
Polycystic Kidney Disease
J and D Pharmaceuticals LLC
0 catalysts
JENTADUETO XR
JENTADUETO XR (LINAGLIPTIN AND METFORMIN HYDROCHLORIDE)
BOEHRINGER INGELHEIM
0 catalysts
Phase 2
JIN-A02
Non-Small Cell Lung Cancer
J Ints Bio Co Ltd
0 catalysts
Phase 2
JK-07
Diastolic Heart Failure (HFpEF)
Salubris Biotherapeutics Inc
0 catalysts
Preclinical
JLK-247
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome )
Phoenix Nest Inc
0 catalysts
Phase 1
JMKX-1899
Colorectal Cancer
HUYA Bioscience International LLC
0 catalysts
Phase 3
JNJ-1900
Head And Neck Squamous Cell Carcinoma (HNSC)
$JNJJOHNSON & JOHNSON
0 catalysts
Phase 2
JNJ-2056
Alzheimer's Disease
Johnson & Johnson Innovative Medicine
0 catalysts
Phase 3
JNJ-69968054
Escherichia coli Infections
$JNJJOHNSON & JOHNSON
0 catalysts
Phase 2
JNS-101
Friedreich Ataxia
$JUNSJUPITER NEUROSCIENCES, INC.
0 catalysts
Phase 1
JNS-107
MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-L…
$JUNSJUPITER NEUROSCIENCES, INC.
0 catalysts
Preclinical
JNS-108
Mild Cognitive Impairment
$JUNSJUPITER NEUROSCIENCES, INC.
0 catalysts
Phase 1
JNS-115
Parkinson's Disease
$JUNSJUPITER NEUROSCIENCES, INC.
0 catalysts
JOURNAVX
JOURNAVX (SUZETRIGINE)
1 INDICATIONS AND USAGE JOURNAVX is indicated for the treatment of moderate t…
$VERXVertex, Inc.
0 catalysts
JOYEAUX
JOYEAUX (LEVONORGESTREL AND ETHINYL ESTRADIOL AND FERROUS FUMARATE)
XIROMED
0 catalysts
Phase 1
JPH-034
Glioma
J-Pharma Co Ltd
0 catalysts
Preclinical
JR-220
Alcohol Use Disorder (AUD)
Naprogenix Inc
0 catalysts
Preclinical
JV-MD2 (Omega-3)
Retinopathy Of Prematurity
Jenivision Inc (Inactive)
0 catalysts
Phase 2
JWATM-204
Hepatocellular Carcinoma
Eureka Therapeutics Inc
0 catalysts
Phase 1
JZP-3507
Ependymoma
$JAZZJazz Pharmaceuticals plc
0 catalysts
Phase 1
JZP-898
Gastroesophageal (GE) Junction Carcinomas
$JAZZJazz Pharmaceuticals plc
0 catalysts
Marketed
Jadenu
Jadenu (deferasirox)
Thalassemia
$NVSNOVARTIS AG
0 catalysts
Phase 2
JadiCell ARDS
Acute Respiratory Distress Syndrome
Breathe Biologics Inc
0 catalysts